Intellia Therapeutics, Inc. (NTLA)

12.64 -0.40 (-3.07%) USD  |  NASDAQ  |  Feb 20, 16:00
12.53 -0.11 (-0.87%) After-Hours: 07:22
More

Intellia Therapeutics Annual EBITDA Margin Estimates

Annual EBITDA Margin Estimates Chart

View Annual EBITDA Margin Estimates for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EBITDA Margin Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EBITDA Margin Estimates Range, Past 5 Years

View Annual EBITDA Margin Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EBITDA Margin Estimates Benchmarks

View Annual EBITDA Margin Estimates Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade